These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Occupational reproductive health and pregnancy hazards confronting health care workers. Gonzalez C AAOHN J; 2011 Sep; 59(9):373-6. PubMed ID: 21877669 [No Abstract] [Full Text] [Related]
44. Challenges in drug use near term and during delivery. Farine D Can J Clin Pharmacol; 2007; 14(1):e29-33. PubMed ID: 17213507 [No Abstract] [Full Text] [Related]
45. Oral health care during pregnancy recommendations for oral health professionals. Kumar J; Samelson R N Y State Dent J; 2009 Nov; 75(6):29-33. PubMed ID: 20069785 [TBL] [Abstract][Full Text] [Related]
46. Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Qasqas SA; McPherson C; Frishman WH; Elkayam U Cardiol Rev; 2004; 12(4):201-21. PubMed ID: 15191632 [TBL] [Abstract][Full Text] [Related]
47. Does it matter if I'm 'just' pregnant? Rio I Aust Fam Physician; 2010 Nov; 39(11):814-9. PubMed ID: 21301652 [TBL] [Abstract][Full Text] [Related]
48. Use of antiepileptic drugs in pregnancy. Tatum WO Expert Rev Neurother; 2006 Jul; 6(7):1077-86. PubMed ID: 16831120 [TBL] [Abstract][Full Text] [Related]
49. [Which drugs are allowed, which should one avoid, which are contraindicated?]. Stahlmann R; Neubert D Gynakologe; 1987 Jun; 20(2):129-36. PubMed ID: 2887491 [No Abstract] [Full Text] [Related]
50. Creating normality in a high-risk pregnancy. Lindsay P Pract Midwife; 2006 Jan; 9(1):16-9. PubMed ID: 16425679 [No Abstract] [Full Text] [Related]
51. [Report and recommendation by the French Academy of Medicine concerning the prevention risks for the child to come and the necessity for early information before pregnancy]. Dreux C; Crépin G; Gynecol Obstet Fertil; 2006; 34(7-8):665-9. PubMed ID: 16815727 [No Abstract] [Full Text] [Related]
52. Prevalence of violence against pregnant women and associated maternal and neonatal complications in Leon, Mexico. Romero-Gutiérrez G; Cruz-Arvizu VH; Regalado-Cedillo CA; Ponce-Ponce de León AL Midwifery; 2011 Oct; 27(5):750-3. PubMed ID: 20870319 [TBL] [Abstract][Full Text] [Related]
54. Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population. Yang T; Walker MC; Krewski D; Yang Q; Nimrod C; Garner P; Fraser W; Olatunbosun O; Wen SW Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):270-7. PubMed ID: 18181228 [TBL] [Abstract][Full Text] [Related]
55. World Health Organization fact sheet. Making pregnancy safer. World Health Organization Saudi Med J; 2004 Aug; 25(8):1133-5. PubMed ID: 15457606 [No Abstract] [Full Text] [Related]
57. [Intrauterine exposure to drugs. Analysis of a sample of newborn infants pretreated with anticonvulsants]. Lazzaroni Fossati F; de Toni T; Magnani M; Repetto E; Calvi A; Di Siena G Minerva Pediatr; 1986 Feb; 38(3-4):75-81. PubMed ID: 3702846 [No Abstract] [Full Text] [Related]
58. Caution advised in interpretation of US FDA risk classification for dermatological medications during pregnancy. Wong JW; Heller MM; Murase JE Dermatol Online J; 2012 Oct; 18(10):15. PubMed ID: 23122022 [TBL] [Abstract][Full Text] [Related]
59. [Iatrogenic risk of self-medication by the pregnant patient]. Bouvier N; Trenque T; Gabriel R; Quereux C; Millart H Presse Med; 2001 Jan; 30(1):37-40. PubMed ID: 11210588 [TBL] [Abstract][Full Text] [Related]
60. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Mitchell AA; Gilboa SM; Werler MM; Kelley KE; Louik C; Hernández-Díaz S; Am J Obstet Gynecol; 2011 Jul; 205(1):51.e1-8. PubMed ID: 21514558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]